EQS — News: mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
EQS-News: mAbxience / Key word(s): Agreement/Miscellaneous mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide 18.09.2026 / 12:35 CET/CEST The issuer is solely responsible for the content of this announcement. ═══════════════════════════════════════════════════════════════════════